Parallel regulation of arginine transport and nitric oxide synthesis by angiotensin II in vascular smooth muscle cells. Role of protein kinase C

Amino Acids

Volumn 11, Issue 2, 1996, Pages 153-170

  Rivera Correa, M ^a   Altieri, P I ^a   Escobales, N ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Amino acids; Angiotensin II; Arginine transport; Nitric oxide; Protein kinase C; Smooth muscle cells

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ARGININE; ASPARAGINE; CARRIER PROTEIN; CYTOKINE; GLUTAMINE; HOMOARGININE; INTERLEUKIN 1BETA; LOSARTAN POTASSIUM; LYSINE; NITRIC OXIDE; NITRITE; ORNITHINE; PHENYLALANINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; SODIUM ION; STAUROSPORINE;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0029814478     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Anand-Srivastava SM (1983) Angiotensin II receptors negatively coupled to adenylate cyclase in rat aorta. Biochem Biophys Res Commun 177: 420-428
2. Boerner P, Saier M (1982) Growth regulation and amino acid transport in epithelial cells: Influence of culture conditions and transformation on A, ASC and L transport activities. J Cell Physiol 113: 240-246
3. Cendan J, Souha W, Copeland E III, Lind DS (1995) Cytokines regulate endotoxin stimulation of endothelial cell arginine transport. Surgery 117: 213-219
4. Chiu AT, Herblin WF, McCall DE (1991) Angiotensin-II type 1 receptors in rat vascular smooth muscle cells. Receptor 1: 134-140
5. Chobanian AV, Haudenschild C, Nickerson C, Drago R (1990) Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 15: 327-331
6. Cohen SA, De Antonis K (1994) Applications of amino acid derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate: analysis of feed grains, intravenous solutions and glycoproteins. J Chromatography 661: 25-34
7. Collarini E, Oxender D (1987) Mechanisms of transport of amino acids across membranes. Ann Rev Nutr 7: 75-90
8. Daemen MJAP, Lombardi D, Bosman FT, Schwartz S (1991) Angiotensin II induces smooth muscle cell proliferation in the normal and in the injured rat arterial wall. Circ Res 68: 450-456
9. Dickerman HW, Walker WG (1964) Effect of cationic amino acid infusion on potassium metabolism in vivo. Am J Physiol 206: 403-408
10. Durante W, Lao L, Schafer A (1995) Differential regulation of L-arginine transport and inducible NOS in cultured vascular smooth muscle cells. Am J Physiol 268: H1158-H1164
11. 2+. Microcirculation 1: 49-58
12. Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777
13. Geng Y, Wu Q, Hansson GK (1994) Protein kinase C activation inhibits cytokine-induced nitric oxide synthesis in vascular smooth muscle cells. Biochim Biophys Acta 1223: 125-132
14. Gibbons GH, Pratt RE, Dzau V (1990) Vascular myocyte hypertrophy vs hyperplasia: Autocrine transforming growth factor-beta determines response to angiotensin II. Clin Res 38: 287 (Abs)
15. 15N]nitrate in biological fluids. Anal Biochem 126: 131-138
16. Greene B, Pacitti A, Souba WW (1993) Characterization of L-arginine transport by pulmonary artery endothelial cells. Am J Physiol 264: L351-L356
17. Griendling K, Rittenhouse S, Brock TA, Ekstein LS, Gimbrone M, Alexander RW (1986) Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem 261: 5901-5906
18. Griendling K, Terutaka T, Berk B, Alexander RW (1989) Angiotensin II stimulation of vascular smooth muscle. J Cardiovasc Pharmacol 14 [Suppl] 16: S27-S33
19. Griendling K, Alexander RW (1990) Angiotensin, other pressors, and the transduction of vascular smooth muscle contraction. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiolotiy, diagnosis and management. Raven Press, New York, pp 583-600
20. Harrap SB, Van der Merwe WM, Griffin S, Macpherson F, Lever AF (1990) Brief ACE inhibitor treatment in young hypertensive rats reduces blood pressure long term. Hypertension 16: 603-614
21. Hibbs JB, Vavrin Z, Taintor RR (1987) L-Arginine is required for the expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 138: 550-565
22. Ip JH, Fuster V, Badimon L, Taubman MB, Chesebro J (1990) Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle proliferation. J Am Coll Cardiol 15: 1667-1687
23. Ignarro LJ, Fukuto J, Griscavage J (1994) Oxidation of nitric oxide (NO) in aqueous solution to nitrite but not nitrate: comparison with enzimatically formed NO from 1-arginine. FASEB J 8: A2076 (Abs)
24. Kilberg M, Handlogten M, Christensen H (1980) Characteristics of an amino acid transport system in rat liver for glutamine, asparagine, histidine and closely related analogs. J Biol Chem 225: 4011-4019
25. Kilberg M, Stevens B, Novak D (1993) Recent advances in mammalian amino acid transport. Annu Rev Nutr 13: 137-165
26. + and cationic amino acid transporter gene expression in cultured vascular smooth muscle cells. J Biol Chem 270: 27577-27583
27. + amino acid transport activity in cultured vascular cells. J Cell Physiol 156: 626-634
28. Misko T, Moore W, Kasten T, Nickols G, Corbert J, Tilton R, McDaniel M, Williamson J, Currie M (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Europ J Pharmacol 233: 119-125
29. Moncada S, Palmer RMJ, Higgs EA (1989) Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication. Biochem Pharmacol 38: 1709-1715
30. Moncada S, Higgs E, Palmer R (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142
31. Moreno A, Lobaton CD, Oxender DL (1985) Regulation of amino acid transport system L by amino acid availability in CHO-K1 cells. A special role for leucine. Biochim Biophys Acta 819: 271-274
32. Naftilan AJ, Pratt RE, Eldrige C, Lin H, Dzau VJ (1989) Angiotensin II induces c-fos expression in smooth muscle via transcriptional control. Hypertension 13: 706-711
33. Naftilan AJ, Pratt RE, Dzau VJ (1989) Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 83: 1419-1424
34. Naftilan AJ, Gilliland G, Eldrige C, Kraft A (1990) Induction of protooncogene c-jun by Angiotensin II. Mol Cell Biol 10: 5536-5540
35. Nakayama Y, Tsuda KT, Okuda M, Yokoyama M (1994) Angiotensin II inhibits cytokine-stimulated inducible nitric synthase expression in vascular smooth muscle cells. J Biol Chem 269: 11628-11633
36. Nunokawa Y, Tanaka S (1992) Interferon-γ inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. Biochim Biophys Res Comm 188: 409-415
37. Peach MJ (1977) Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57: 313-370
38. Powell JS, Clozel J, Müller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner H (1989) Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245: 186-188
39. Raines E, Ross R (1993) Smooth muscle cells and the pathogenesis of the lessions of atherosclerosis. Br Heart J 69 [Suppl]: S30-S37
40. Re RN (1981) Cellular biology of the renin-angiotensin system. Arch Intern Med 144: 2037-2041
41. Rivera-Correa M, Altieri PI, Escobales N (1995) Characterization of L-arginine transport in smooth muscle cells and its regulation by angiotensin II. Amino Acids 9: 23 (Abs)
42. Rozengurt E (1986) Early signals in the mitogenic response. Science 234: 161-166
43. Rubanyi G (1993) The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 22 [Suppl] 4: S1-S14
44. Saier M, Daniels G, Boerner P, Lin J (1981) Neutral amino acid transport systems in animal cells: potential targets of oncogene action and regulators of cellular growth. J Membrane Biol 104: 1-20
45. Sakuma I, Stuehr D, Gross S, Nathan C, Levi R (1988) Identification of arginine as a precursor of endothelium-dependent relaxing factor. Proc Natl Acad Sci USA 85: 8664-8667
46. Smith JB (1986) Angiotensin-receptor signaling in cultured vascular smooth muscle cells. Am J Physiol 250: F759-F769
47. Travo P, Barret G, Burnstock G (1980) Differences in proliferation of vascular smooth muscle cells taken from male and female rats. Blood Vessels 17: 110-116
48. Timmermans PB, Benfield P, Chiu AT, Herblin WF, Wong PC, Smith RD (1992) Angiotensin II receptors and functional correlates. Am J Hypertens 5 [Suppl]: 221-235
49. +-dependent transport of basic, zwitterionic, and bicyclic amino acids by a broad-scope system in mouse blastocysts. J Biol Chem 260: 12118-12123
50. Walsh MP, Andrea JE, Allen BG, Clement-Chomienne O, Collins EM, Morgan KG, (1994) Smooth muscle protein kinase C. Can J Phsiol Pharmacol 72: 1392-1399
51. White M, Gazzola G, Christensen H (1982) Cationic amino acid transport into cultured animal cells. J Biol Chem 257: 4443-4449
52. White MF (1985) The transport of cationic amino acids across the plasma membrane of mammalian cells. Biochim Biophys Acta 822: 355-374
53. Wong PC, Price W, Chiu A, Duncia JV, Carini DJ, Wexler R, Johnson A, Timmermans P (1990) Hypotensive action of DUP 753, an Angiotensin II antagonist, in spontaneously hypertensive rats. Hypertension 15: 459-468